[Therapy of pheochromocytoma].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D010643:Phenoxybenzamine / Q000627:therapeutic use; D010646:Phentolamine / Q000627:therapeutic use; D010673:Pheochromocytoma / Q000188:drug therapy / Q000601:surgery*; D011247:Pregnancy; D012110:Reserpine / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000970:Antineoplastic Agents; D006993:Hypnotics and Sedatives; D010643:Phenoxybenzamine; D012110:Reserpine; D010646:Phentolamine
Terapia del feocromocitoma.